Dr. Peter Bridgman, a retired neurologist who has cancer, is a man on a mission to get funding restored for federal agencies that are conducting cancer research.

Bridgman, 72, was diagnosed with multiple myeloma in 2013. Multiple myeloma is a bone marrow cancer that is treatable with infusion therapies.

The Yarmouth resident said he is doing well and is thankful for the treatments that are keeping him alive, but he is concerned about the future of cancer research.

Advanced cancer treatment options are under development at the National Institutes of Health (NIH) and National Cancer Institute (NCI), but the federal agencies face funding cuts in the billions.

"NIH and the NCI expected small cuts like five or 10 percent, but they were completely floored by the 37 percent cut to the NCI," B

See Full Page